In a Phase I study, 8 out of 12 patients with relapsed and/or chemotherapy refractory blood cancers responded to a combination of the chemotherapy drugs thioguanine and decitabine; some of the responders had relapsed after treatment with decitabine alone, report researchers.
from Top Health News – ScienceDaily http://bit.ly/2gu8s7E
from Tumblr http://bit.ly/2gHQnGh
No comments:
Post a Comment